Intrinsiqq
Jin Medical International Ltd. logo

Jin Medical International Ltd.

ZJYL

⊜ Compare

Jin Medical International Ltd. designs, develops, manufactures and markets wheelchairs and rehabilitation medical equipment for people with disabilities, the elderly and individuals recovering from injury. The company's product portfolio includes manual and electric wheelchairs, wheelchair components, walking aids, oxygen concentrators, micro-hyperbaric oxygen chambers and nano-thermal bathing equipment. Jin Medical also offers lifestyle beauty and health devices, shampoo instruments and shared wheelchair infrastructure to support mobility and daily living needs. The company operates manufacturing facilities in Changzhou, Taizhou and Chuzhou across Jiangsu and Anhui provinces in China, serving markets across mainland China, Japan, the United States, Hong Kong, Singapore, Korea and Australia. Founded in 2006 and headquartered in Changzhou, China, Jin Medical positions itself as an industrial leader in assistive technologies and rehabilitation equipment, emphasizing research and development to drive product innovation and expand its presence in rehabilitation and health-related markets globally.

Valuation & Multiples

Based on TTM earnings · Diluted shares

Market Cap$26M
EPS$0.16
P/E19.13
P/FCF-7.09
EV/EBITDA16.37
FCF Yield–
Div. Yield–
Net Debt/FCF2.9x
Jin Medical International Ltd. intrinsic value
52-Week Range
$1.81$5.58

Profitability & Returns

Revenue (TTM)

$21M

▼ -12.0% YoY

Net Income (TTM)

$1M

▼ -59.6% YoY

Op. Margin

2.94%

▼ -12.5pp YoY

ROIC

1.19%

▼ -7.5pp YoY

Cash Flow & Balance Sheet

FCF (TTM)

-$4M

▼ -59.8% YoY

Op. Cash Flow (TTM)

$4M

▲ +713.8% YoY

Net Debt

-$11M

Net Cash Position

Cash & Equiv.

$30M

3Y CAGR: +2.5%

Continue Research

Peers

Medical Instruments & Supplies · Pick stocks to compare with ZJYL

CompareIntrinsic value
CASIFCasi Pharmaceuticals Inc
$0.10-9.09%8
ALGEN.XPARGenoway S.A.
€1.92-7.93%22
NICA.XSTONanologica AB
€0.00-11.11%30
ALNOV.XPARNovacyt S.A.
€0.43+1.79%33
NYXHNyxoah SA
$0.86-1.22%40
MEDCL.XPARMedincell SA
€28.68+3.02%40
ALKLH.XPARKlea Holding Inc.
€0.15+7.81%80
IVACC.XSTOIntervacc AB
€0.06+17.67%40

Jin Medical International (ZJYL) in four numbers

Fair value (earnings)
$2.87
Price $3.09 is 8% above it.
Intrinsic Value
Quality score
37/100
Best check: share count change, -94.3%. Weakest: return on capital, 1.2%.
Quality
Dividend
None
No dividend in the company filings we hold.
Dividends
P/E
19.13
Price to free cash flow -7.09.
Financials

Questions about Jin Medical International

Is Jin Medical International (ZJYL) overvalued?

At $3.09, Jin Medical International's price is 8% above the $2.87 a share fair value that Intrinsiqq's calculator gets from its earnings. It trades at 19.13 times earnings. The growth behind that figure is yours to set on the Intrinsic Value tab. See how to tell if a stock is overvalued.

What is Jin Medical International's fair value?

Intrinsiqq's calculator puts Jin Medical International's fair value at $2.87 a share. It grows earnings per share 20% a year for 5 years, applies an exit P/E of 30, and works back at a 10% yearly return. A 25% margin of safety gives a buy-below price of $2.15. Every input can be changed on the Intrinsic Value tab.

Is Jin Medical International a high-quality business?

Jin Medical International scores 37 out of 100 on Intrinsiqq's quality score, which makes it a lower-quality business on these measures. The score blends 7 checks computed from company filings. Its best check is share count change at -94.3%, and its weakest is return on capital at 1.2%. The Quality tab shows every check against its target.

Does Jin Medical International (ZJYL) pay a dividend?

No. Jin Medical International (ZJYL) does not pay a dividend, and no dividend payment appears anywhere in the filing history we hold. Nor has its share count fallen meaningfully over the last twelve months, so cash is kept in the business. The Dividends tab shows its cash returns.

Source: company filings. Price: last close 4 Nov 2026. How this is calculated. Sector medians are approximate S&P 500 benchmarks and update periodically. Analysis, not investment advice.

Spot a number that looks wrong?

Download this analysis as a PDF (Pro)

Data sourced from company filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing ZJYL

Create a free account and get 14 days of Premium: every stock and every tool.

  • Unlimited stocks
  • Stock screener
  • Portfolio tracker
  • Editable DCF
  • Compare side by side
  • Unlimited alerts

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.

SectorsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.